SCHEMBL6168341

SCHEMBL6168341

Cc1ccc2[nH]c(=O)c(-c3ccccc3)cc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DAO P14920 1/20 0.57
▸ HSD17B10 Q99714 5/20 0.52
▸ MAOB P27338 1/20 0.51
▸ KDM4E B2RXH2 8/20 0.51
▸ HPGD P15428 5/20 0.51
▸ ALDH1A1 P00352 5/20 0.51
▸ MAPT P10636 4/20 0.51
▸ CTDSP1 Q9GZU7 2/20 0.50
▸ APOBEC3A P31941 1/20 0.50
▸ APOBEC3G Q9HC16 1/20 0.50
▸ PIN1 Q13526 1/20 0.49
▸ CA12 O43570 1/20 0.49
▸ CA9 Q16790 1/20 0.49
▸ ADORA3 P0DMS8 1/20 0.48
▸ NPC1 O15118 2/20 0.48
▸ RAB9A P51151 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ ATM Q13315 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29206326 0.82 BRD4 (0.64) DAOHSD17B10KDM4EHPGDALDH1A1
SCHEMBL2008746 0.81 KDR (0.68) DAOHSD17B10KDM4EHPGDALDH1A1
SCHEMBL29712353 0.81 KDR (0.68) DAOHSD17B10KDM4EHPGDALDH1A1
SCHEMBL30875870 0.81 CYP19A1 (0.61) HSD17B10MAOBHPGDALDH1A1MAPT
SCHEMBL17505156 0.81 NPC1 (0.51) HSD17B10KDM4EHPGDALDH1A1MAPT
SCHEMBL10980382 0.81 KMT2A (0.61) DAOHSD17B10KDM4EALDH1A1MAPT
SCHEMBL9270293 0.81 SMAD3 (0.50) DAOHPGDALDH1A1MAPTCTDSP1
SCHEMBL29206329 0.81 CYP19A1 (0.61) HSD17B10MAOBHPGDALDH1A1MAPT
SCHEMBL7196311 0.80 ALDH1A1 (0.70) HSD17B10KDM4EHPGDALDH1A1MAPT
SCHEMBL27255974 0.77 KDM4E (0.57) HSD17B10KDM4EHPGDALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097138-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING 2-QUINOLONES LAFON LABOR (FR) 2005-12-07 — — EP disclosed
CN-1195740-C Pharmaceutical composition containing 2-quinolinone LAFON LABOR (FR) 2005-04-06 — — CN disclosed
US-6593342-B1 Activity on the proliferation of clonogenic cells in tumours and comprising an efficient amount of a compound selected among the compounds LABORATOIRE L. LAFON (FR) 2003-07-15 — — US disclosed
CN-1309639-A Pharmaceutical composition containing 2-quinolinone LAFON LABOR (FR) 2001-08-22 — — CN disclosed
EP-1097138-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING 2-QUINOLONES LABORATOIRE L. LAFON (FR) 2001-05-09 — — EP disclosed
WO-2000003990-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING 2-QUINOLONES LABORATOIRE L. LAFON (FR) 2000-01-27 — — WO disclosed
Send feedback